Stemgent
StemEdit hiPSC CIITA KO RPC-LLF-34-F3
| Cat # | Size |
|---|---|
| RCRP051 | 1 Vial |
Have questions?
Overview
Ready-to-use Research-Grade HLA Class II knockout iPSCs made using REPROCELL’s RNA Reprogramming Technology.
These cells feature all the advantages of our RNA reprogramming technology, including no retention of reprogramming factors and easy culture in NutriStem hPSC XF Medium. They have been engineered using OpenCRISPR-1 to contain a CIITA (HLA Class II) knockout mutation, which is carefully characterized and offers significant time savings compared to creating your own reprogrammed and edited cell lines.
The parent line, StemRNA Clinical iPSC Clone LLF-34-F3, is also available for clinical and research use. Please contact us for more info,
| Cat. No.: | RCRP051 |
| Parent Clone ID | StemRNA Clinical iPSC Clone LLF-34-F3 |
| Donor Race: | Caucasian |
| Donor Sex: | Female |
| Donor Age: | 22 |
| Reprogramming Technology: | StemRNA Reprogramming Technology |
| Tissue Source: | Skin (Fibroblasts) |
| Karyotype: | Normal (46 XX) |
| Microbiology: | Negative for bacteria, virus, mycoplasma |